TransMedics Group, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
TransMedics Group, Inc. (TMDX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 0.20% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-02-24
- TransMedics Group, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2025 was 0.20%, a 93.55% decline from fiscal 2024.
- TransMedics Group, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was 3.10%.
- TransMedics Group, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -1.20%.
- TransMedics Group, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -0.70%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.20% 10-K · filed 2026-02-24 | |
| 2024-12-31 | 3.10% 10-K · filed 2026-02-24 | -3.10% 10-K · filed 2025-02-27 |
| 2023-12-31 | -1.20% 10-K · filed 2026-02-24 | |
| 2022-12-31 | -0.70% 10-K · filed 2025-02-27 | 2.80% 10-K · filed 2023-02-27 |
| 2021-12-31 | -0.10% 10-K · filed 2024-02-27 | 3.20% 10-K · filed 2022-03-01 |
| 2020-12-31 | 0.20% 10-K · filed 2023-02-27 | |
| 2019-12-28 | -0.20% 10-K · filed 2021-03-11 | |
| 2018-12-29 | -1.40% 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |